SCIRENT was founded as a cardiovascular CRO in 2012 with the vision to help clients develop innovative medical drugs and devices for patients with cardiovascular diseases. Our dedicated team of experienced clinical and regulatory professionals shares your enthusiasm for developing effective therapies for heart patients.
We create value for our customers by functioning as an interface between our clients and sites, authorities, key opinion leaders, and other parties offering on-going advice and support to optimize processes and workflows.
Our senior leadership continually overviews the clinical trial process, ready to give advice or implement feedback throughout the clinical trial process.
Our young and highly educated staff is passionate about solving problems that might occur on-site quickly to navigate complexity and reach sponsor goals on time.
Our company collaborates with specialized cardiovascular sites with high performance in patient enrollment and care – even when it comes to demanding procedures requiring specialist know-how and equipment.
specialized cardiovascular sites
of our staff have an
academic degree
countries covered with a strong
European focus
full-time employees
Hans-Dirk Duengen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Elvis Tahirovic is a Co-founder and Managing Director at SCIRENT. He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.
Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.
Our site network covers 20 countries across the globe with a focus on Europe and North America.
* Partner Network
